BlackBerry Ltd (NASDAQ:BBRY) is making good progress in its turnaround. According to a report from RBC Capital Markets, published on May 5, 2014, things are looking much better at the Canadian firm, “with the restructuring achieved” a quarter earlier, and also hardware profitability now “seeming within reach”. BlackBerry Ltd (NASDAQ:BBRY) stock performance was -4.95% in last session and finished the day at $ 7.29. Traded volume was 13,952,218 shares in the last session and the average volume of the stock remained 18,420,000 shares. The beta of the stock remained 0.48. BlackBerry Ltd (NASDAQ:BBRY) insider ownership is 15.01%.

RF Micro Devices (NASDAQ:RFMD)’s CFO William Priddy sold 21,644 shares of the company’s stock on the open market in a transaction dated Monday, May 5th. The stock was sold at an average price of $8.50, for a total transaction of $183,974.00. Following the sale, the chief financial officer now directly owns 563,042 shares in the company, valued at approximately $4,785,857. RF Micro Devices, Inc. (NASDAQ:RFMD) rose 1.48% percent to $ 8.90 yesterday on volume of 12,531,805 shares. The intra-day range of the stock was $ 8.73 – 8.90. RF Micro Devices, Inc. (NASDAQ:RFMD) has a market capitalization of $ 2.52 billion.

Canadian Solar (NASDAQ:CSIQ)’s shares were the recipient of some unusual options trading on Monday. Investors bought 14,169 call options on the company,American Banking and Market News reports. This is an increase of 460% compared to the average volume of 2,528 call options. Canadian Solar Inc. (NASDAQ:CSIQ)’s stock on May 7, 2014 reported a increase of 0.96% to the closing price of $ 27.25. Its fifty two weeks range is $ 5.25 – 44.50. The total market capitalization recorded $1.38 billion. The overall volume in the last trading session was 6,333,456 shares. In its share capital, Canadian Solar Inc.(NASDAQ:CSIQ) has 54.77 million outstanding shares.

Corcept Therapeutics (NASDAQ:CORT) announced its earnings results on Wednesday. The company reported ($0.11) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.09) by $0.02, AmericanBankingNews.com reports. On Friday, shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)dropped -50.50% to close the day at $ 1.99. Company return on investment (ROI) is -74.10% and its monthly performance is recorded as -50.99%. Corcept Therapeutics Incorporated (NASDAQ:CORT)quarterly revenue growth is -34.54%.